From: Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon
Public
Private
Other
Number of matched medicines
17
14
14 (OB)
4 (LPG)
MPR - OB
1.77
24.11
1.89
26.71
MPR - LPG
27.92
29.72
% Difference
1264.90%
1316.90%
0.00% OB/ 6.40% LPG